Marrone Bio Innovations Inc. (MBII) Upgraded by Zacks Investment Research to “Hold”

Zacks Investment Research upgraded shares of Marrone Bio Innovations Inc. (NASDAQ:MBII) from a sell rating to a hold rating in a report released on Wednesday.

According to Zacks, “Marrone Bio Innovations Inc. develops environmentally safe bio-based products. The Company specializes in the discovery, development, and marketing of natural products for weed, pest, water resource, and plant disease management. It offers crop protection products for conventional and organic crop production, including herbicides for weed control, fungicides for plant disease control, nematicides for parasitic roundworm control, insecticides for insect and mite killers and plant growth regulators that growers use to increase crop yields, enhance plant health, manage pest resistance, and reduce chemical residues. Marrone Bio Innovations Inc. is headquartered in Davis, California. “

Shares of Marrone Bio Innovations (NASDAQ:MBII) opened at 1.72 on Wednesday. The stock has a 50 day moving average price of $1.61 and a 200 day moving average price of $1.03. The firm’s market cap is $42.34 million. Marrone Bio Innovations has a 12-month low of $0.60 and a 12-month high of $3.69.

Marrone Bio Innovations (NASDAQ:MBII) last announced its quarterly earnings data on Tuesday, August 9th. The company reported ($0.28) EPS for the quarter, meeting the Thomson Reuters’ consensus estimate of ($0.28). Marrone Bio Innovations had a negative return on equity of 2,083.14% and a negative net margin of 304.71%. The business had revenue of $5 million for the quarter, compared to the consensus estimate of $4.61 million. On average, equities analysts expect that Marrone Bio Innovations will post ($1.12) earnings per share for the current year.

Marrone Bio Innovations Company Profile

Marrone Bio Innovations, Inc offers bio-based pest management and plant health products. The Company’s bio-based products include naturally occurring microorganisms, such as bacteria, fungi and plant extracts. It sells its products to crop protection market. Its four crop protection products include Regalia, Grandevo, Venerate and Majestene.

5 Day Chart for NASDAQ:MBII

Get a free copy of the Zacks research report on Marrone Bio Innovations (MBII)

For more information about research offerings from Zacks Investment Research, visit

Receive News & Ratings for Marrone Bio Innovations Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marrone Bio Innovations Inc. and related companies with's FREE daily email newsletter.

Leave a Reply

© 2006-2016 Mideast Time.